Prophylactic versus on‐demand treatment strategies for severe haemophilia: a comparison of costs and long‐term outcome
The DOI matches its Crossref record.
Abstract
Summary. A multicentre study was performed to compare clotting factor use and outcome between on‐demand and prophylactic treatment strategies for patients with severe haemophilia. Data on treatment and outcome of 49 Dutch patients with severe haemophilia, born 1970–80, primarily treated with prophylaxis, were compared with those of 106 French patients, who were primarily treated on demand. Dutch patients received intermediate dose prophylaxis, for a median duration of 12.7 years. Patients primarily treated with prophylaxis had fewer joint bleeds per year (median 2.8 vs. 11.5), a higher proportion of patients without joint bleeds (29% vs. 9%), lower clinical scores (median 2.0 vs. 8.0), and less arthropathy as measured by the Pettersson score (median 7 points vs. 16 points). Mean annual clotting factor use was equal at 1488 ± 783 IU kg−1 year−1 (mean ± standard deviation) for patients primarily treated with prophylaxis and 1612 ± 1442 IU kg−1 year−1 for patients primarily treated on demand. These findings suggest that, compared with a primarily on‐demand treatment strategy, a primarily prophylactic treatment strategy leads to better outcome at equal treatment costs in young adults with severe haemophilia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Hemophilia joint health score reliability study
HILLIARD, P., FUNK, S., ZOURIKIAN, N., BERGSTROM, B. ‐., BRADLEY, C. S., MCLIMONT, M., MANCO‐JOHNSON, M., PETRINI, P., VAN DEN BERG, M., & FELDMAN, B. M. (2006) · Haemophilia · doi:10.1111/j.1365-2516.2006.01312.x · Cited by 339
KONKLE, B. A., EBBESEN, L. S., ERHARDTSEN, E., BIANCO, R. P., LISSITCHKOV, T., RUSEN, L., & SERBAN, M. A. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02663.x · Cited by 327
Collins, P. W., Blanchette, V. S., Fischer, K., Björkman, S., Oh, M., Fritsch, S., Schroth, P., Spotts, G., Astermark, J., & Ewenstein, B. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03270.x · Cited by 323
Self-citationVALENTINO, L. A., MAMONOV, V., HELLMANN, A., QUON, D. V., CHYBICKA, A., SCHROTH, P., PATRONE, L., & WONG, W. ‐. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04611.x · Cited by 253
A feasibility study on two tailored interventions to improve adherence in adults with haemophilia
Hoefnagels, J. W., Fischer, K., Bos, R. A. T., Driessens, M. H. E., Meijer, S. L. A., Schutgens, R. E. G., & Schrijvers, L. H. (2020) · Pilot and Feasibility Studies · doi:10.1186/s40814-020-00723-w · Cited by 24
“Non-adherence and inadequate treatment of bleeds can cause irreversible damage, especially in a joint or the central nervous system [8].”
BackgroundSelf-citation
Metadata
- Authors
- Fischer, K., Van der Bom, J. G., Molho, P., Negrier, C., Mauser‐Bunschoten, E. P., Roosendaal, G., De Kleijn, P., Grobbee, D. E., & Van Den Berg, H. M.
- Venue
- Haemophilia
- Publisher
- Wiley
- Published
- 2002-10-30
- Volume
- 8
- Issue
- 6
- Pages
- 745-752
- ISSN
- 1351-8216 (ISSN-L)
- 1365-2516
- OpenAlex
- W2084425785
- Cited by
- 209
- References
- 0
- FWCI
- 3.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prophylactic versus on‐demand treatment strategies for severe haemophilia: a comparison of costs and long‐term outcome. https://app.cochat.ai/papers/10.1046/j.1365-2516.2002.00695.x
- The paper
- Fischer, K., Van der Bom, J. G., Molho, P., Negrier, C., Mauser‐Bunschoten, E. P., Roosendaal, G., De Kleijn, P., Grobbee, D. E., & Van Den Berg, H. M. (2002). Prophylactic versus on‐demand treatment strategies for severe haemophilia: a comparison of costs and long‐term outcome. Haemophilia. https://doi.org/10.1046/j.1365-2516.2002.00695.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.